BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36579810)

  • 21. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
    Hong S; Yan Z; Song Y; Bi M; Li S
    Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
    Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer.
    Zhang Z; Ye B; Lin Y; Liu W; Deng J; Ji W
    Clin Transl Oncol; 2023 Nov; 25(11):3217-3229. PubMed ID: 37184781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis.
    Guo Z; Liu X; Shao H
    Dig Liver Dis; 2022 Jul; 54(7):878-889. PubMed ID: 34838479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
    Cui G; Zhao H; Li L
    J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6.
    Wei AW; Li LF
    Biomed Pharmacother; 2017 Dec; 96():953-959. PubMed ID: 29217166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF8-AS1 displays low expression in colorectal cancer and up-regulates RASSF8 to suppress cell invasion and migration.
    Zhang X; Sun P; Yang W; Li S; Jia H; Wang W; Jiang S; Wang L; Liu X; Liang L; Zi W
    Pathol Res Pract; 2022 Sep; 237():153996. PubMed ID: 35839610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1.
    Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX
    J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.
    Chen G; Gu Y; Han P; Li Z; Zhao JL; Gao MZ
    J Cell Physiol; 2019 Aug; 234(10):18688-18696. PubMed ID: 30912164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer.
    Mo S; Zhang L; Dai W; Han L; Wang R; Xiang W; Wang Z; Li Q; Yu J; Yuan J; Cai S; Cai G
    Cell Death Dis; 2020 Feb; 11(2):155. PubMed ID: 32111819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
    Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
    Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.